Identification of drug-resistant subpopulations in canine hemangiosarcoma

A Khammanivong1, B H Gorden1, A M Frantz1

  • 1Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, St. Paul, MN, USA.

Insights

Canine hemangiosarcoma exhibits drug resistance due to unique cell populations identified in sphere cultures. These cells show enhanced chemotherapy resistance and altered transporter expression, offering new therapeutic targets.

Area of Science:

  • Veterinary Oncology
  • Cancer Cell Biology
  • Drug Resistance Mechanisms

Background:

  • Canine hemangiosarcoma is aggressive and poorly responsive to chemotherapy.
  • Drug resistance is a significant obstacle in treating this canine cancer.
  • Novel strategies are needed to overcome therapeutic limitations.

Purpose of the Study:

  • To investigate drug resistance mechanisms in canine hemangiosarcoma.
  • To identify drug-resistant cell populations using progenitor cell-derived spheres.
  • To explore the role of ATP-binding cassette (ABC) transporters in resistance.

Main Methods:

  • Utilized progenitor cell populations from canine hemangiosarcoma cell lines.
  • Cultured cells as non-adherent spheres to mimic tumor microenvironment.
  • Assessed chemotherapy drug resistance, side population expansion, and ABC transporter expression.
  • Conducted invasion studies on sphere and monolayer cell populations.

Main Results:

  • Sphere-forming cells demonstrated enhanced resistance to chemotherapy drugs.
  • Increased populations of dye-excluding side cells were observed in spheres.
  • Altered expression of ATP-binding cassette (ABC) transporters was noted.
  • Invasion capabilities varied between cell lines and culture types.

Conclusions:

  • Sphere cell populations harbor distinct drug-resistant subpopulations.
  • Multiple mechanisms, including ABC transporter alterations, contribute to drug evasion.
  • This sphere culture model provides a novel tool for studying hemangiosarcoma drug resistance.
  • Findings may inform new therapeutic approaches for canine hemangiosarcoma.